Keystone Financial Services Laboratory Corp Of America Holdings Transaction History

Keystone Financial Services

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$211.93 - $241.33 $9,536 - $10,859	-45 Reduced 3.54%	1,226 $295,000
Q1 2023 Apr 28, 2023	BUY	$213.32 - $257.83 $4,693 - $5,672	22 Added 1.76%	1,271 $291,000
Q4 2022 Feb 01, 2023	SELL	$203.72 - $248.97 $9,574 - $11,701	-47 Reduced 3.63%	1,249 $293,000
Q3 2022 Oct 28, 2022	BUY	$204.81 - $262.19 $7,168 - $9,176	35 Added 2.78%	1,296 $280,000
Q2 2022 Aug 03, 2022	BUY	$213.86 - $277.87 $7,057 - $9,169	33 Added 2.69%	1,261 $318,000
Q1 2022 May 10, 2022	SELL	$259.82 - $298.18 $80,544 - $92,435	-310 Reduced 20.16%	1,228 $323,000
Q4 2021 Feb 01, 2022	BUY	$271.6 - $314.21 $417,720 - $483,254	1,538 New	1,538 $484,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.8B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Keystone Financial Services, based on Form 13F filings with the SEC.

Stay updated on Keystone Financial Services with notifications on news.